Medication info
Harurosin Extended-Release Capsule 0.2 mg (Tamsulosin Hydrochloride)

Harurosin Extended-Release Capsule 0.2 mg (Tamsulosin Hydrochloride)

Prescription medicationOral
Ingredient · strength
Tamsulosin Hydrochloride›0.2mg / 1 capsule
Manufacturer / importer
Daewoong Pharmaceutical Co., Ltd.
Appearance
An apricot-colored capsule with a white to light yellow pellet inside.
Packaging
30 capsules/bottle, 60 capsules/bottle
Approval status
Active

MFDS item code 201906878 · Approved 2019.09.26 · Insurance code 641606970

Summary

Main use
Improvement of voiding symptoms associated with benign prostatic hyperplasia
Who takes it
Adults
Adult dose
Adults: Administer tamsulosin hydrochloride 0.2 mg orally once daily after a meal. Swallow this medicine whole; do not crush or chew it. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Daewoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of voiding symptoms associated with benign prostatic hyperplasia

  • Urinary disorders
View approved original text

This medication is used to alleviate urinary disorders caused by benign prostatic hyperplasia, such as difficulty urinating or frequent urges to urinate.

How to take

Adult dose

Adults: Administer tamsulosin hydrochloride 0.2 mg orally once daily after a meal. Swallow this medicine whole; do not crush or chew it. Adjust the dose appropriately according to symptoms.

Precautions

This medication should not be used in certain patients. Firstly, individuals who have had an allergic reaction to this drug or its constituents should not take it. Additionally, patients with orthostatic hypotension may experience worsening symptoms, so this medication should not be used. Patients with severely impaired liver function may have increased drug concentrations in the blood, so it should not be administered. Women who are pregnant or may become pregnant should also avoid this medication. This drug should be used with caution in patients with severely reduced kidney function or in the elderly. Patients taking PDE5 inhibitors, CYP3A4 inhibitors, or antihypertensives should also be careful as interactions may occur. In particular, patients taking alpha-1 blockers should generally not use this medication unless absolutely necessary and with careful consideration. Similarly, patients with a history of urinary-related syncope need cautious administration. Serious side effects such as syncope or loss of consciousness may occur while taking this drug, so monitoring is important. Neurological symptoms such as dizziness, headache, drowsiness, insomnia, and nervousness may also appear. Cardiovascular symptoms may include palpitations, arrhythmias, and drop in blood pressure; caution should be taken. If allergy symptoms such as skin rash or itching develop, the medication should be stopped immediately. Gastrointestinal symptoms may include nausea, vomiting, abdominal pain, constipation, and diarrhea. Liver function abnormalities or jaundice may occur, so liver status should be checked periodically. Additionally, there have been reports of nasal congestion, edema, incontinence, visual disturbances, dermatitis, and in rare cases, severe skin reactions or priapism as dangerous side effects. During administration, care should be taken to avoid overdose, and since blood pressure may drop suddenly when standing, it is advisable to move slowly. This medication is a symptomatic treatment, so if it does not work, other treatment methods such as surgery should be considered. Caution should be exercised when driving or operating machinery due to dizziness that may cause accidents. This drug belongs to the alpha-1 blocker class, and severe side effects such as priapism may occur rarely, so if these symptoms arise, immediate consultation with medical personnel is necessary. Moreover, during cataract or glaucoma surgery, intraoperative floppy iris syndrome may appear, so medical personnel should be informed of the use of this medication before surgery. Patients with a history of sulfa drug allergy are at risk of allergic reactions when taking this medication, so extra caution is required. This drug may cause blood pressure to drop too low when taken with other antihypertensives or PDE5 inhibitors, so dosage adjustment and monitoring are essential during concurrent use. Some antibiotics, antifungals, and antidepressants may also have interactions, so it is imperative to inform medical personnel of all medications being taken. Pregnant women and children under 18 years of age should not use this medication as its safety and efficacy have not been established. The elderly may have reduced kidney function, so it should be started at a low dose while observing the patient's condition. If it is ineffective, do not increase the dose further and consider alternative treatments. This medication is in capsule or extended-release tablet form, and it should be taken whole without chewing or opening the capsule as this may alter its efficacy. In particular, the capsule should be swallowed whole, and the orally disintegrating tablet should be taken with water or allowed to dissolve on the tongue.

Side effects

Fainting, loss of consciousness, dizziness, abnormal sense of balance, orthostatic dizziness, headache, drowsiness, nervousness, insomnia, decreased libido, anxiety, numbness, tachycardia, low blood pressure, orthostatic hypotension, palpitations, arrhythmia, rash, itching, hives, nausea, vomiting, discomfort in the stomach area, feeling of fullness, stomach pain, loss of appetite, thirst, constipation, diarrhea, dental disorders, swallowing difficulties, elevated AST, elevated ALT, jaundice, burning sensation in the throat, general malaise, nasal congestion, nosebleed, edema, urinary incontinence, altered taste, gynecomastia, priapism, infection, lethargy, back pain, chest pain, rhinitis, pharyngitis, increased cough, sinusitis, abnormal ejaculation, amblyopia, intraoperative iris tension reduction syndrome, blurred vision, visual impairment, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, photosensitivity reaction, chest discomfort, shortness of breath, sexual dysfunction, redness, tinnitus, tongue skin disorders, lip skin disorders, facial skin disorders, skin peeling

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air or moisture. It is also important to keep it at room temperature (between 1°C and 30°C) and avoid locations that are too hot or too cold.

Appearance and packaging

Appearance

An apricot-colored capsule with a white to light yellow pellet inside.

Package unit

30 capsules/bottle, 60 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.